Moomoo AI 已提取核心信息
AbbVie Inc. officer, Azita Saleki-Gerhardt, is set to sell 52,870 shares of the company's common stock on February 21, 2024, according to a recent filing. The shares, valued at approximately $9,184,486.84, were acquired on the same date through a stock option exercise as part of compensation from the issuer. This transaction follows a period where no significant sales activity was reported by Saleki-Gerhardt in the past three months.
AbbVie Inc. officer, Azita Saleki-Gerhardt, is set to sell 52,870 shares of the company's common stock on February 21, 2024, according to a recent filing. The shares, valued at approximately $9,184,486.84, were acquired on the same date through a stock option exercise as part of compensation from the issuer. This transaction follows a period where no significant sales activity was reported by Saleki-Gerhardt in the past three months.
根据最近的一份文件，艾伯维公司高管阿齐塔·萨利基·格哈特定于2024年2月21日出售该公司52,870股普通股。这些股票价值约9,184,486.84美元，是作为发行人薪酬的一部分，于同日通过股票期权行使收购。此次交易是在Saleki-Gerhardt在过去三个月中没有报告任何重大销售活动之后进行的。
根据最近的一份文件，艾伯维公司高管阿齐塔·萨利基·格哈特定于2024年2月21日出售该公司52,870股普通股。这些股票价值约9,184,486.84美元，是作为发行人薪酬的一部分，于同日通过股票期权行使收购。此次交易是在Saleki-Gerhardt在过去三个月中没有报告任何重大销售活动之后进行的。
有用
没用
